Total planned funding: $28,434,842
Clear active filters
U.S. Department of State
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Mozambique | $8,779,304 |
| South Africa | $6,761,014 |
| Zambia | $2,043,344 |
| Tanzania | $1,438,500 |
| Botswana | $1,313,637 |
| Uganda | $1,241,579 |
| Kenya | $1,134,015 |
| Caribbean Region | $1,000,000 |
| Ethiopia | $966,790 |
| Malawi | $605,950 |
| Lesotho | $554,399 |
| Zimbabwe | $502,000 |
| Côte d'Ivoire | $365,008 |
| Ghana | $315,000 |
| Nigeria | $303,000 |
| Eswatini | $296,365 |
| Vietnam | $265,000 |
| Rwanda | $212,136 |
| Cameroon | $150,000 |
| Central America Region | $98,784 |
| Guyana | $64,017 |
| Namibia | $25,000 |
| Democratic Republic of the Congo | $0 |
Organizational Types
| Own Agency | $10,108,852 |
| Other USG Agency | $9,337,222 |
| Implementing Agency | $6,803,394 |
| NGO | $2,185,374 |
Program Areas
| Management and Operations | $7,200,336 |
| Care | $6,701,282 |
| Prevention | $6,475,986 |
| Governance and Systems | $6,156,521 |
| Testing | $1,226,662 |
| Treatment | $674,055 |
Budget Codes
| HVMS: Management and Operations | $7,200,336 |
| HKID: Care: Orphans and Vulnerable Children | $4,982,067 |
| OHSS: Health Systems Strengthening | $4,486,737 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $2,325,912 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $2,007,171 |
| HBHC: Care: Adult Care and Support | $1,533,652 |
| HVCT: Testing: HIV Testing and Counseling | $1,226,662 |
| HLAB: Laboratory Infrastructure | $1,080,704 |
| HMBL: Biomedical Prevention: Blood Safety | $1,000,000 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $804,571 |
| HVSI: Strategic Information | $589,080 |
| HTXS: Treatment: Adult Treatment | $501,205 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $334,518 |
| PDCS: Care: Pediatric Care and Support | $93,417 |
| PDTX: Treatment: Pediatric Treatment | $92,146 |
| HVTB: Care: TB/HIV | $92,146 |
| HTXD: Treatment: ARV Drugs | $80,704 |
| HMIN: Biomedical Prevention: Injection Safety | $3,814 |